Rockefeller Capital Management L.P. Purchases 92,516 Shares of Ingevity Corporation $NGVT

Rockefeller Capital Management L.P. lifted its position in shares of Ingevity Corporation (NYSE:NGVT) by 3,998.1% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 94,830 shares of the company’s stock after purchasing an additional 92,516 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in Ingevity were worth $5,612,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Global Retirement Partners LLC purchased a new stake in Ingevity in the fourth quarter worth approximately $27,000. Meeder Asset Management Inc. bought a new position in Ingevity during the fourth quarter valued at approximately $33,000. Geneos Wealth Management Inc. raised its stake in shares of Ingevity by 85.8% during the second quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock worth $36,000 after acquiring an additional 387 shares in the last quarter. Headlands Technologies LLC purchased a new position in shares of Ingevity during the second quarter worth approximately $46,000. Finally, Kestra Advisory Services LLC bought a new stake in shares of Ingevity in the 4th quarter worth approximately $47,000. Institutional investors own 91.59% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on NGVT shares. Wall Street Zen raised shares of Ingevity from a “buy” rating to a “strong-buy” rating in a research note on Sunday, June 21st. Weiss Ratings reissued a “sell (d-)” rating on shares of Ingevity in a research note on Tuesday, April 21st. Wells Fargo & Company upped their price target on shares of Ingevity from $65.00 to $75.00 and gave the company an “equal weight” rating in a research report on Friday, February 27th. Finally, BMO Capital Markets reaffirmed an “outperform” rating and set a $83.00 price objective on shares of Ingevity in a research note on Monday, March 2nd. Two investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $80.00.

Ingevity Trading Up 3.1%

NYSE:NGVT opened at $76.47 on Friday. The firm has a market capitalization of $2.66 billion, a P/E ratio of -21.54 and a beta of 1.18. The company has a quick ratio of 0.92, a current ratio of 1.42 and a debt-to-equity ratio of 27.83. The company has a fifty day moving average of $71.37 and a 200 day moving average of $68.56. Ingevity Corporation has a 52 week low of $39.74 and a 52 week high of $79.29.

Ingevity (NYSE:NGVT) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.84 by $0.31. Ingevity had a negative net margin of 10.55% and a positive return on equity of 207.82%. The business had revenue of $258.00 million for the quarter, compared to analyst estimates of $254.73 million. During the same quarter last year, the firm earned $1.01 EPS. The company’s revenue was up 4.1% on a year-over-year basis. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. On average, research analysts predict that Ingevity Corporation will post 5.05 earnings per share for the current year.

Insider Buying and Selling at Ingevity

In other news, SVP Terrance M. Dyer sold 496 shares of the stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $68.49, for a total transaction of $33,971.04. Following the completion of the sale, the senior vice president directly owned 7,202 shares in the company, valued at approximately $493,264.98. This represents a 6.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.88% of the company’s stock.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.